Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

Real-time Quote. Real-time Tradegate - 02/11 12:22:21 pm
12.25 EUR   -3.92%
02/03 CYTOTOOLS : strenghthens DermaTools Biotech GmbH with a  capital inc..
2015 CYTOTOOLS : DermaPro retains its potential
2015 CYTOTOOLS : before important milestones
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
02/05/2016 02/08/2016 02/09/2016 02/10/2016 02/11/2016 Date
14(c) 13.22(c) 12.495(c) 12.75(c) 12.25 Last
4 951 8 554 11 989 955 2 948 Volume
-2.64% -5.57% -5.48% +2.04% -3.92% Change
More quotes
Financials (€)
Sales 2015 1,50 M
EBIT 2015 -2,60 M
Net income 2015 -2,60 M
Finance 2015 0,20 M
Yield 2015 -
Sales 2016 2,60 M
EBIT 2016 -1,30 M
Net income 2016 -1,30 M
Debt 2016 0,50 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales 2015 16,0x
EV / Sales 2016 9,51x
Capitalization 24,2 M
More Financials
Company
CytoTools AG operates as a biotechnology company, which develops therapeutic from research on programmed death cell.The company was founded by Dirk Kaiser and Mark-Andre Freyberg in 2000 and is headquartered in Darmstadt, Germany. 
More about the company
Latest news on CYTOTOOLS AG
02/03 CYTOTOOLS : strenghthens DermaTools Biotech GmbH with a  capital increase
02/03 CYTOTOOLS : stärkt das Tochterunternehmen DermaTools Biotech GmbH durch Kapitale..
01/26 CYTOTOOLS : klärt die Ursachen der zu geringen Wirkstoffkonzentration auf, die z..
2015 CYTOTOOLS : DermaPro retains its potential
2015 CYTOTOOLS : berichtet: Der Wirkstoff DermaPro(R) behält sein Potential (DGAP New..
2015 CYTOTOOLS : berichtet über Ergebnisse der europäischen klinischen Studie Phase I..
2015 CYTOTOOLS : before important milestones
2015 CYTOTOOLS : vor wichtigen Meilensteinen: Indische Zulassungsbehörden empfehlen Z..
More news
Sector news : Bio Therapeutic Drugs
09:28aDJU.S. HOT STOCKS : Hot Stocks to Watch
09:16aDJIncyte Reports Profit But Scraps Trials Involving Cancer Drug
08:51a INCYTE : discontinues JANUS 1 study of ruxolitinib plus capecitabine
More sector news : Bio Therapeutic Drugs


Comments 
Advertisement
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions